Eugene Melnyk Wiki, Biography, Age, Spouse, Net Worth, Fast Facts

Melnyk died “after an illness which he faced with seriousness and audacity,” according to the group’s statement. Melnyk had a liver transfer in 2015, but the group did not discuss his illness. Melnyk, a Toronto local and the son of Ukrainian tutors, bought the Senators for $92 million in 2003.

How did Eugene Melnyk make his money? Eugene Melnyk amassed a fortune in the drug business. He filed a claim in April 2016 against the CEO and director of Acerus Pharmaceuticals, which Melynk helped establish in 2008. Eugene’s health misfortune later crushed the organization, and the company was demolished in 2015.

He sought $145 million in damages. Melynk also claims the NHL’s Ottawa Senators and its AHL member, who moved from Binghamton, New York, to Belleville, Ontario, for the 2016-2017 season. Another pitch for the big club is at the center of a deal brokered by a Melynk-backed group that won the option to redevelop the capital’s LeBreton Flats last year.

Melnyk was a pioneer in the field of designing a business to take advantage of tax breaks. He moved to Barbados and deployed many of the organization’s activities there, including a licensed innovation arm that planned R&D around the world. However, lately it has struggled with the role structure of Valeant Pharmaceuticals, which merged with Biovail in 2010, allowing it to benefit from lower Canadian spend rates.

Eugene Melnyk Net Worth in 2022 Explored Eugene Melnyk’s total assessed assets are $1.2 billion. He was the current and sole owner, principal representative, and director of the Ottawa Senators of the National Hockey League (NHL).

It is with great sadness that the family of Eugene Melnyk and the Ottawa Senators hockey organization announce his passing on March 28, 2022 after an illness that he faced with determination and courage. https://t.co/MrHsTvu7sz pic.twitter.com/DOZrJcD26e

— Ottawa Senators (@Senators) March 29, 2022

He established and served as Director and CEO of Biovail Corporation, which was later purchased by Valeant Pharmaceuticals. Melnyk was ranked 77th in Canadian Business magazine’s 2014 roundup of the 100 richest people in the country, with total assets of $1 billion. Eugene Melnyk: All in his career Eugene Melnyk was a Canadian money manager, donor and owner, principal representative.

He was also the executive for the Ottawa Senators of the National Hockey League (NHL) and the Belleville Senators of the American Hockey League (AHL). He is the creator, former executive and CEO of Biovail Corporation, once the largest public pharmaceutical organization in Canada with annual revenues of more than 1 billion Canadian dollars.

By 2010, he had sold virtually all of his shares in the organization. Melnyk was ranked 79th in Canadian Business magazine’s 2017 roundup of the 100 most affluent people in Canada, with total assets of $1.21 billion. He was probably the richest occupant of Barbados.